Literature DB >> 26885105

Effect of transsphenoidal surgery and standard care on fertility related indicators of patients with prolactinomas during child-bearing period.

Zhiyue Yan1, Yiming Wang2, Xuefei Shou3, Jianguang Su4, Liwei Lang1.   

Abstract

OBJECTIVE: To explore the surgical therapeutic effects in the endocrine and reproductive system of women with prolactinoma at child-bearing age, and to investigate the potential influencing factors for therapeutic outcome.
METHODS: This retrospective study was performed using the medical records of 99 cases of female patients with pituitary PRL adenomas at child-bearing age, who underwent transsphenoidal surgery and took standard perioperative care from January, 2013 to June, 2013 in Huashan hospital, in which micro adenoma (≤1 cm) of 68 cases, large adenomas (> 1 cm) of 31 cases, 88 cases were total resection, 9 cases were subtotal resection, and 2 cases were massive resection. Retrospective study on the preoperative serum level of PRL, menstruation, galactorrhea and reproductive function, etc. Patients were followed up in 1, 3, 6 and 12 months after operation for endocrine indicators, the situation of menstruation and pregnancy.
RESULTS: Overall, 88.9%, 9.1%, and 2% patients underwent total, subtotal, and massive resection of prolactinoma in 99 cases of patients. Before accepting transsphenoidal surgery and standard care, all 99 cases with serum PRL level higher than normal 25 ng/ml, 71.7% (71 cases, all total resection) patients had their serum PRL < 25 ng/ml on the first day after surgery, and micro adenomas remission rate of 80.9% (55 cases) was significantly higher than 51.6% of large adenomas (16 cases) (P < 0.05); the postoperative PRL of 11 cases of total or massive resection in patients were not back to normal, Chi-square test results showed that the PRL remission rate after total resection were significantly higher than that of subtotal or massive resection (P < 0.01). 67.3% (66/98) irregular menstruation patients had menstruation recovery after surgery, in addition, total resection of the tumor, micro- adenoma, preoperative PRL < 200 ng/ml and first day of postoperative PRL ≤25 ng/ml were favorable factors for menstrual improvement (P < 0.05). 83.6% (51/61) of patients with galactorrhea symptoms got alliviated after surgery, but had no association to the types of tumor (P > 0.05). 14 patients out of 17 infertility patients got pregnant after surgery.
CONCLUSION: Transsphenoidal operation combining standardized nursing measures is an effective way to treat pituitary PRL adenoma, and it has high cure rate on abnormal menstruation caused by pituitary PRL adenoma which can recover the fertility of female patients. The preoperative serum level of prolactin could be used as an indicator for postoperative improvement in the endocrine system. The serum level of prolactin on the first day after operation could accurately reflect prognosis, so be regarded as one of the assessment factors for surgical therapeutic effect.

Entities:  

Keywords:  Woman; endocrine; menstruation; prolactinoma

Year:  2015        PMID: 26885105      PMCID: PMC4723950     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  19 in total

Review 1.  Disorders of prolactin secretion.

Authors:  M E Molitch
Journal:  Endocrinol Metab Clin North Am       Date:  2001-09       Impact factor: 4.741

2.  Transsphenoidal pituitary resection for preoperative diagnosis of prolactin-secreting pituitary adenoma in women: long term follow-up.

Authors:  S L Feigenbaum; D E Downey; C B Wilson; R B Jaffe
Journal:  J Clin Endocrinol Metab       Date:  1996-05       Impact factor: 5.958

Review 3.  Managing the patient with transsphenoidal pituitary tumor resection.

Authors:  Wen Yuan
Journal:  J Neurosci Nurs       Date:  2013-04       Impact factor: 1.230

4.  Surgical results of growth hormone-secreting pituitary adenoma.

Authors:  Min-Su Kim; Hyun-Dong Jang; Oh-Lyong Kim
Journal:  J Korean Neurosurg Soc       Date:  2009-05-31

5.  Surgical treatment of prolactin-secreting pituitary adenomas: early results and long-term outcome.

Authors:  Marco Losa; Pietro Mortini; Raffaella Barzaghi; Lorenzo Gioia; Massimo Giovanelli
Journal:  J Clin Endocrinol Metab       Date:  2002-07       Impact factor: 5.958

Review 6.  [Recent trends in the pathophysiology and treatment of pituitary adenomas].

Authors:  Akira Matsuno
Journal:  Brain Nerve       Date:  2009-08

7.  Endoscopic transsphenoidal treatment of pituitary adenomas.

Authors:  Yazhuo Zhang; Zhongcheng Wang; Yejian Liu; Xuyi Zong; Ming Song; Ao Pei; Peng Zhao; Pengfei Zhang; Mingxue Piao
Journal:  Neurol Res       Date:  2008-07       Impact factor: 2.448

8.  Endoscopic endonasal transsphenoidal approach through the bilateral nostrils for pituitary adenomas.

Authors:  Shigetoshi Yano; Takayuki Kawano; Mareina Kudo; Keishi Makino; Hideo Nakamura; Yutaka Kai; Motohiro Morioka; Jun-ichi Kuratsu
Journal:  Neurol Med Chir (Tokyo)       Date:  2009-01       Impact factor: 1.742

9.  Gamma knife in the treatment of pituitary adenomas: results of a single center.

Authors:  F A Zeiler; M Bigder; A Kaufmann; P J McDonald; D Fewer; J Butler; G Schroeder; M West
Journal:  Can J Neurol Sci       Date:  2013-07       Impact factor: 2.104

Review 10.  Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis.

Authors:  Ferdinand Roelfsema; Nienke R Biermasz; Alberto M Pereira
Journal:  Pituitary       Date:  2012-03       Impact factor: 4.107

View more
  3 in total

Review 1.  Gross total resection of pituitary adenomas after endoscopic vs. microscopic transsphenoidal surgery: a meta-analysis.

Authors:  Reem D Almutairi; Ivo S Muskens; David J Cote; Mark D Dijkman; Vasileios K Kavouridis; Erin Crocker; Kholoud Ghazawi; Marike L D Broekman; Timothy R Smith; Rania A Mekary; Hasan A Zaidi
Journal:  Acta Neurochir (Wien)       Date:  2018-01-06       Impact factor: 2.216

2.  Long-term follow-up of female prolactinoma patients at child-bearing age after transsphenoidal surgery.

Authors:  Na Yi; Lijin Ji; Qi Zhang; Shuo Zhang; Xiaoxia Liu; Xuefei Shou; Bin Lu
Journal:  Endocrine       Date:  2018-06-22       Impact factor: 3.633

3.  Are dopamine agonists still the first-choice treatment for prolactinoma in the era of endoscopy? A systematic review and meta-analysis.

Authors:  Xiangming Cai; Junhao Zhu; Jin Yang; Chao Tang; Zixiang Cong; Chiyuan Ma
Journal:  Chin Neurosurg J       Date:  2022-04-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.